- Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
E. Ciruelos et al, 2020, Clinical and Translational Oncology CrossRef - Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association
Tochi M. Okwuosa et al, 2021, Circulation: Genomic and Precision Medicine CrossRef - Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer
Fatih YILDIZ et al, 2020, Journal of Surgery and Medicine CrossRef - New and Emerging Targeted Therapies for Advanced Breast Cancer
Kristie H. Lau et al, 2022, International Journal of Molecular Sciences CrossRef